

IQVIA experts explore the ongoing impact of COVID-19 on European pharmaceutical markets, including unique insights from HCPs on the prescription of newly launched products as well as a renewed focus on the continued impact of COVID-19 on cancer care, with new learnings from IQVIA’s Oncology Dynamics Team.
Sarah Rickwood, VP, European Thought Leadership & Marketing
Caroline Anger, Associate Director, Global Oncology Offering Development
Dr Nicole Friedersdorf, Global Oncology Associate Product & Strategy Director.